Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK.
about
Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicinesAssessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation.Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents
P2860
Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Comparison of pregnancy and la ...... the USA, Denmark, and the UK.
@en
Comparison of pregnancy and la ...... the USA, Denmark, and the UK.
@nl
type
label
Comparison of pregnancy and la ...... the USA, Denmark, and the UK.
@en
Comparison of pregnancy and la ...... the USA, Denmark, and the UK.
@nl
prefLabel
Comparison of pregnancy and la ...... the USA, Denmark, and the UK.
@en
Comparison of pregnancy and la ...... the USA, Denmark, and the UK.
@nl
P2860
P1433
P1476
Comparison of pregnancy and la ...... the USA, Denmark, and the UK.
@en
P2093
Lise Aagaard
Pernille Warrer
P2860
P2888
P304
P356
10.1007/S40264-014-0215-2
P577
2014-10-01T00:00:00Z